
eQuine Holdings discloses 8% stake in AngioSoma (SOAN)
eQuine Holdings has filed a form 13D with the SEC disclosing an 8% stake in AngioSoma (SOAN), after announcing its LOI for the acquisition of Diabetes Relief AngioSoma (OTC:SOAN) DALLAS, TEXAS, USA, December 27, 2018 /EINPresswire.com/ -- eQuine Holdings, a Class II Multi-Family Office, has disclosed an eight percent (8%) equity stake in AngioSoma (SOAN) On December 17, 2018 AngioSoma announced a Partially Binding Letter of Intent to acquire Diabetes Relief. A copy of SEC form 13D can be found at …